LeMaitre Vascular, Inc. (LMAT) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lemaitre Vascular, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.256 Hello, good day. This is RG, your conference operator today, and we welcome 00:00:05.256 -- 00:00:10.541 you to the Lumetri Vascular Q3 2025 Financial Results 00:00:10.541 -- 00:00:14.705 Conference Call. As a reminder, today's call is being recorded. 00:00:14.705 -- 00:00:18.849 At this time, I would like to turn the call over to Mr. 00:00:18.849 -- 00:00:24.053 Dorian LeBlanc, Chief Financial Officer of Lumetri Vascular. 00:00:24.053 -- 00:00:26.794 Please go ahead, sir. 00:00:28.498 -- 00:00:33.827 Thank you. Good afternoon, and thank you for joining us on our Q3 2025 00:00:33.827 -- 00:00:38.977 conference call. With me on today's call is our CEO, George LeMaitre, and our President, 00:00:38.977 -- 00:00:44.046 Dave Roberts. Before we begin, I'll read our safe harbor statement. 00:00:44.046 -- 00:00:47.371 Today, we'll be making some forward-looking statements within the meaning of the U.S. 00:00:47.371 -- 00:00:52.280 Private Securities Litigation Reform Act of 1995, the accuracy of which is subject to 00:00:52.280 -- 00:00:56.495 risks and uncertainties. Wherever possible, we will try to identify those forward-looking 00:00:56.495 -- 00:01:01.540 statements by using words such as believe, expect, anticipate, pursue, 00:01:01.540 -- 00:01:06.465 forecast, and similar expressions. Our forward-looking statements are based on our estimates 00:01:06.465 -- 00:01:11.570 and assumptions as of today, November 6, 2025, and should not be relied upon 00:01:11.570 -- 00:01:15.254 as representing our estimates or views on any subsequent date. 00:01:15.254 -- 00:01:18.698 Please refer to the cautionary statement regarding forward-looking information and the 00:01:18.698 -- 00:01:23.157 risk factors in our most recent 10-K and subsequent SE...